XML 32 R20.htm IDEA: XBRL DOCUMENT
v3.20.2

Note 13 - Fair Value Measurements | 6 Months Ended
--- | ---
Jun. 30, 2020
Notes to Financial Statements |
Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block] | 1 3. Fair Value Measurement s The Company determined the fair values of our financial instruments based on the following:
| • | Level 1 - Quoted prices in active markets for identical assets or liabilities.
| • | Level 2 - Observable prices in active markets for similar assets or liabilities; prices for identical or similar assets or liabilities in markets that are not active; directly observable market inputs for substantially the full term of the asset and liability; market inputs that are not directly observable but are derived from or corroborated by observable market data.
| • | Level 3 – Unobservable inputs based on the Company’s own judgment about the assumptions that a market participant would use.
The Company uses the following methodologies to measure the fair value of its financial assets and liabilities on a recurring basis: Securities Available for Sale - For certain U.S. Treasury securities, the Company measures the fair value based on quoted market prices in active exchange markets at the reporting date, a Level 1 measurement. The Company also measures securities by using quoted market prices for similar securities or dealer quotes, a Level 2 measurement. This category generally includes U.S. Government agency securities, U.S. Government sponsored entities, state and municipal securities, mortgage-backed securities (“MBS”), collateralized mortgage obligations and corporate bonds. Equity Securities – The Company measures the fair value based on quoted market prices in active exchange markets at the reporting date, a level 1 measurement. Equity securities are comprised of mutual funds, preferred stock of government-sponsored entities and other equity securities. Foreign Exchange Contracts - The Company measures the fair value of foreign exchange contracts based on dealer quotes, a Level 2 measurement. Warrants - The Company measures the fair value of warrants based on unobservable inputs based on assumptions and management judgment, a Level 3 measurement. Interest Rate Swaps - Fair value of interest rate swaps is derived from third party models with observable market data, a Level 2 measurement. Assets measured at estimated fair value on a non-recurring basis: Certain assets or liabilities are required to be measured at estimated fair value on a nonrecurring basis subsequent to initial recognition. Generally, these adjustments are the result of lower-of-cost-or-fair value or other impairment write-downs of individual assets. In determining the estimated fair values during the period, the Company determined that substantially all the changes in estimated fair value were due to declines in market conditions versus instrument specific credit risk. For the periods ended June 30, 2020 and December 31, 2019, there were no material adjustments to fair value for the Company’s assets and liabilities measured at fair value on a nonrecurring basis in accordance with GAAP. The following tables present the Company’s hierarchy for its assets and liabilities measured at fair value on a recurring basis as of June 30, 2020, and December 31, 2019:
|  | June 30, 2020 |  |  |  |  |
|  | Fair Value Measurements Using |  |  | Total Fair Value |
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Measurements |
|  | (In thousands) |
Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities available-for-sale |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
U.S. Treasury securities |  | $ | 99,927 |  |  | $ | — |  |  | $ | — |  |  | $ | 99,927 |
U.S. government agency entities |  |  | — |  |  |  | 107,393 |  |  |  | — |  |  |  | 107,393 |
Mortgage-backed securities |  |  | — |  |  |  | 802,412 |  |  |  | — |  |  |  | 802,412 |
Collateralized mortgage obligations |  |  | — |  |  |  | 301 |  |  |  | — |  |  |  | 301 |
Corporate debt securities |  |  | — |  |  |  | 136,069 |  |  |  | — |  |  |  | 136,069 |
Total securities available-for-sale |  | $ | 99,927 |  |  | $ | 1,046,175 |  |  | $ | — |  |  | $ | 1,146,102 |
Equity securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Mutual funds |  | $ | 6,431 |  |  | $ | — |  |  | $ | — |  |  | $ | 6,431 |
Preferred stock of government sponsored entities |  |  | 4,868 |  |  |  | — |  |  |  | — |  |  |  | 4,868 |
Other equity securities |  |  | 13,271 |  |  |  | — |  |  |  | — |  |  |  | 13,271 |
Total equity securities |  | $ | 24,570 |  |  | $ | — |  |  | $ | — |  |  | $ | 24,570 |
Warrants |  | $ | — |  |  | $ | — |  |  | $ | 13 |  |  | $ | 13 |
Interest rate swaps |  |  | — |  |  |  | 3,842 |  |  |  | — |  |  |  | 3,842 |
Foreign exchange contracts |  |  | — |  |  |  | 1,529 |  |  |  | — |  |  |  | 1,529 |
Total assets |  | $ | 124,497 |  |  | $ | 1,051,546 |  |  | $ | 13 |  |  | $ | 1,176,056 |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Option contracts |  | $ | — |  |  | $ | 6 |  |  | $ | — |  |  | $ | 6 |
Interest rate swaps |  |  | — |  |  |  | 33,760 |  |  |  | — |  |  |  | 33,760 |
Foreign exchange contracts |  |  | — |  |  |  | 531 |  |  |  | — |  |  |  | 531 |
Total liabilities |  | $ | — |  |  | $ | 34,297 |  |  | $ | — |  |  | $ | 34,297 |
|  | December 31, 2019 |  |  |  |  |
|  | Fair Value Measurements Using |  |  | Total Fair Value |
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Measurements |
|  | (In thousands) |
Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities available-for-sale |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
U.S. Treasury securities |  | $ | 74,936 |  |  | $ | — |  |  | $ | — |  |  | $ | 74,936 |
U.S. government agency entities |  |  | — |  |  |  | 90,796 |  |  |  | — |  |  |  | 90,796 |
U.S. government sponsored entities |  |  | — |  |  |  | 224,443 |  |  |  | — |  |  |  | 224,443 |
Mortgage-backed securities |  |  | — |  |  |  | 887,790 |  |  |  | — |  |  |  | 887,790 |
Collateralized mortgage obligations |  |  | — |  |  |  | 552 |  |  |  | — |  |  |  | 552 |
Corporate debt securities |  |  | — |  |  |  | 173,325 |  |  |  | — |  |  |  | 173,325 |
Total securities available-for-sale |  | $ | 74,936 |  |  | $ | 1,376,906 |  |  | $ | — |  |  | $ | 1,451,842 |
Equity securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Mutual funds |  | $ | 6,277 |  |  | $ | — |  |  | $ | — |  |  | $ | 6,277 |
Preferred stock of government sponsored entities |  |  | 10,529 |  |  |  | — |  |  |  | — |  |  |  | 10,529 |
Other equity securities |  |  | 11,199 |  |  |  | — |  |  |  | — |  |  |  | 11,199 |
Total equity securities |  | $ | 28,005 |  |  | $ | — |  |  | $ | — |  |  | $ | 28,005 |
Warrants |  | $ | — |  |  | $ | — |  |  | $ | 39 |  |  | $ | 39 |
Interest rate swaps |  |  | — |  |  |  | 2,181 |  |  |  | — |  |  |  | 2,181 |
Foreign exchange contracts |  |  | — |  |  |  | 2,411 |  |  |  | — |  |  |  | 2,411 |
Total assets |  | $ | 102,941 |  |  | $ | 1,381,498 |  |  | $ | 39 |  |  | $ | 1,484,478 |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Option contracts |  | $ | — |  |  | $ | 7 |  |  | $ | — |  |  | $ | 7 |
Interest rate swaps |  |  | — |  |  |  | 14,229 |  |  |  | — |  |  |  | 14,229 |
Foreign exchange contracts |  |  | — |  |  |  | 1,415 |  |  |  | — |  |  |  | 1,415 |
Total liabilities |  | $ | — |  |  | $ | 15,651 |  |  | $ | — |  |  | $ | 15,651 |
The Company measured the fair value of its warrants on a recurring basis using significant unobservable inputs. The fair value adjustment of warrants was included in other operating income in the first six months of 2020. The significant unobservable inputs in the Black-Scholes option pricing model for the fair value of warrants are their expected life ranging from 1 to 5 years, risk-free interest rate from 0.29% to 0.60%, and stock volatility from 16.61% to 23.26%. For financial assets measured at fair value on a nonrecurring basis that were still reflected in the Condensed Consolidated Balance Sheets as of June 30, 2020, the following tables set forth the level of valuation assumptions used to determine each adjustment, the carrying value of the related individual assets as of June 30, 2020, and December 31, 2019, and the total losses for the periods indicated:
|  | As of June 30, 2020 |  |  | Total Losses |
|  | Fair Value Measurements Using |  |  | Total Fair |  |  | For the Three Months Ended |  |  | For the Six Months Ended |
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Value Measurements |  |  | June 30, 2020 |  |  | June 30, 2019 |  |  | June 30, 2020 |  |  | June 30, 2019 |
|  | (In thousands) |
Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Impaired loans by type: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Commercial loans |  | $ | — |  |  | $ | — |  |  | $ | 8,968 |  |  | $ | 8,968 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Commercial mortgage loans |  |  | — |  |  |  | — |  |  |  | 19,439 |  |  |  | 19,439 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Residential mortgage loans and equity lines |  |  | — |  |  |  | — |  |  |  | 8,974 |  |  |  | 8,974 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Total impaired loans |  |  | — |  |  |  | — |  |  |  | 37,381 |  |  |  | 37,381 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Other real estate owned (1) |  |  | — |  |  |  | 3,405 |  |  |  | 4,238 |  |  |  | 7,643 |  |  |  | 381 |  |  |  | 422 |  |  |  | 717 |  |  |  | 494 |
Investments in venture capital and private company stock |  |  | — |  |  |  | — |  |  |  | 1,384 |  |  |  | 1,384 |  |  |  | 71 |  |  |  | 16 |  |  |  | 104 |  |  |  | 18 |
Total assets |  | $ | — |  |  | $ | 3,405 |  |  | $ | 43,003 |  |  | $ | 46,408 |  |  | $ | 452 |  |  | $ | 438 |  |  | $ | 821 |  |  | $ | 512 |
(1) Other real estate owned balance of $7.3 million in the condensed consolidated balance sheet is net of estimated disposal costs.
|  | As of December 31, 2019 |  |  | Total Losses/(Gains) |
|  | Fair Value Measurements Using |  |  | Total Fair |  |  | For the Twelve Months Ended |
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Value Measurements |  |  | December 31, 2019 |  |  | December 31, 2018 |
|  | (In thousands) |
Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Impaired loans by type: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Commercial loans |  | $ | — |  |  | $ | — |  |  | $ | 6,196 |  |  | $ | 6,196 |  |  | $ | — |  |  | $ | — |
Commercial mortgage loans |  |  | — |  |  |  | — |  |  |  | 25,566 |  |  |  | 25,566 |  |  |  | — |  |  |  | — |
Residential mortgage loans and equity lines |  |  | — |  |  |  | — |  |  |  | 5,320 |  |  |  | 5,320 |  |  |  | — |  |  |  | — |
Total impaired loans |  |  | — |  |  |  | — |  |  |  | 37,082 |  |  |  | 37,082 |  |  |  | — |  |  |  | — |
Other real estate owned (1) |  |  | — |  |  |  | 6,490 |  |  |  | 4,343 |  |  |  | 10,833 |  |  |  | 681 |  |  |  | (619 | )
Investments in venture capital and private company stock |  |  | — |  |  |  | — |  |  |  | 1,604 |  |  |  | 1,604 |  |  |  | 167 |  |  |  | 330 |
Total assets |  | $ | — |  |  | $ | 6,490 |  |  | $ | 43,029 |  |  | $ | 49,519 |  |  | $ | 848 |  |  | $ | (289 | )
(1) Other real estate owned balance of $10.2 million in the Consolidated Balance Sheets is net of estimated disposal costs. The significant unobservable (Level 3) inputs used in the fair value measurement of collateral for collateral-dependent impaired loans are primarily based on the appraised value of collateral adjusted by estimated sales cost and commissions. The Company generally obtains new appraisal reports every twelve months as appropriate. As the Company’s primary objective in the event of default would be to monetize the collateral to settle the outstanding balance of the loan, less marketable collateral would receive a larger discount. In the current year, the Company used borrower specific collateral discounts with various discount levels. The significant unobservable inputs used in the fair value measurement of other real estate owned (“OREO”) are primarily based on the appraised value of OREO adjusted by estimated sales cost and commissions. The Company applies estimated sales cost and commissions ranging from 3% to 6% of the collateral value of impaired loans, quoted price, or loan sale price of loans held for sale, and appraised value of OREO.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -URI http://asc.fasb.org/topic&trid=2155941 + Details
Name: | us-gaap_FairValueMeasurementInputsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration